Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Derivatives Options or other derivatives
  2. 4 Exercise or conversion Chief Financial Officer acquired 116,690 shares (option exercise)
  3. 4 Planned sale President and CEO sold 137,390 shares at $0.36 ($49,460)
  4. 4 Planned sale General Counsel and Secretary sold 21,287 shares at $0.36 ($7,663)
  5. 4 Planned sale Chief Medical Officer sold 21,526 shares at $0.36 ($7,749)
  6. 4 Open-market sale Chief Research Officer sold 28,000 shares at $0.37 ($10,360)
  7. 4 Planned sale General Counsel and Secretary sold 16,023 shares at $0.40 ($6,409)
  8. 4 Planned sale President and CEO sold 125,025 shares at $0.40 ($50,010)
  9. 4 Exercise or conversion Chief Financial Officer acquired 108,188 shares (option exercise)
  10. 4/A Open-market buy Chief Financial Officer bought 90,000 shares at $0.48 ($43,200)
  11. 4 Grant or award General Counsel and Secretary acquired 5,443 shares (grant or award)
  12. 4 Grant or award Chief Research Officer acquired 5,175 shares (grant or award)
  13. 4 Grant or award Chief Financial Officer acquired 5,951 shares (grant or award)
  14. 4 Grant or award Chief Financial Officer acquired 90,000 shares (grant or award)
  15. 4 Exercise or conversion VP & Corporate Controller acquired 6,060 shares (option exercise)
  16. 4 Exercise or conversion Chief Financial Officer acquired 47,726 shares (option exercise)
  17. 4 Exercise or conversion Chief Research Officer acquired 4,872 shares (option exercise)
  18. 4 Planned sale General Counsel and Secretary sold 13,361 shares at $0.75 ($10,021)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 6 of 14 · 269 filings